Pharma Law USA
The only pharma event examining regulation, pricing, antitrust, IP, AI & compliance in one place.
Your one-stop shop to dissect the latest legal developments in the current geopolitical landscape and gain practical strategies from fellow in-house counsel on how to overcome them.
Brought to you by Informa.
Regulators, in-house counsel, private practice lawyers & economists sharing their insights in 2025 include:
Topics covered in 2025 include:
Current Political Landscape: Healthcare Under the New Administration
Regulators’ Roundtable
Inflation Reduction Act, 340B Drug Program Litigation & Other Developments in Pricing
Antitrust Challenges in the Pharma Sector
Merger Control: Update on FTC Guidelines & New HSR Filing Form
Patents including Orange Book Cases, Patent Settlement & Product Hopping
Biologics & Biosimilars: Antitrust, IP & Other Issues
AI in the Pharma Sector: Risks & Opportunities
Compliance: Best Practice
%
of attendees from corporates and regulators
expert speakers from across the pharma sector sharing their insights
annual conference offering the only one-stop-shop for legal developments affecting the pharma industry
Reasons to attend Informa's Pharma Law USA 2025:
Explore currently developing legal challenges for the pharmaceutical industry, from every angle.
Hear from the pharma industry to gain a holistic perspective on all the developing issues.
Key areas of focus include:
- Regulation & enforcement
- Pricing developments
- Antitrust challenges
- Patents & IP
- Compliance
Reunite with old acquaintances & forge new connections with the pharma industry in Boston:
Attendees include:
- In-house counsel from across the pharma sector
- Private practice lawyers
- Authorities and regulators
- Economists
- Academics
Meet your peers from across the pharma industry during the conference. Connect with them during lunch and networking breaks. Reinforce your connections during the informal drinks reception at the end of the day.
Silver Partners
Showcase your firm to future clients:
Showcase your knowledge and expertise to a top-level audience from across the pharma sector - including a high proportion of in-house counsel.
Get in touch with Natallia Kohut to discuss speaking, branding and exhibition opportunities.
